Skip to content

Lucem Health

2 viewers · 30d

Total raised

$8.4M

+$8.4M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $8.4M
ROUNDS
1
INVESTORS
6
FOUNDED
N/A
HQ
Davidson, NC
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Lucem Health is a clinical AI company that helps health systems find patients at elevated risk of serious disease before symptoms present. Its platform ingests existing patient data from any source, routes it through validated clinical AI models and algorithms, and surfaces the resulting risk insights inside the clinician's existing workflow. The company was founded in 2021 in partnership with Mayo Clinic and is headquartered in Davidson, North Carolina. It runs disease-specific early-detection programs spanning arrhythmia, colorectal cancer, liver disease, lung cancer, stroke, and Type 1 diabetes.

What sets it apart

Rather than selling a single algorithm, Lucem Health is a model-agnostic delivery layer: it connects any clinical AI model to any health system's data and pushes the output into existing clinical workflows, so providers adopt early-detection programs without changing how they practice. It was co-founded with Mayo Clinic, which supplies clinical validation.

Funding history

1 round
Equity+1Mar 26, 2026
Form D
+$8.4M$8.4M total

Latest SEC filings

via EDGAR · CIK 0001971026
Form D · Mar 26, 2026View on EDGAR

Products

1 tracked

Lucem Health Reveal

Clinical AI / population health software

An AI-enabled early disease detection platform that analyzes a health system's existing patient data against validated clinical algorithms and delivers at-risk patient identifications into clinical workflows.

  • Connects healthcare data from any source to any clinical AI model or algorithm
  • Delivers insights inside existing clinical workflows rather than a separate application
  • Disease-specific programs for arrhythmia, colorectal cancer, liver disease, lung cancer, stroke, and Type 1 diabetes
  • Reported detection and screening-efficiency gains such as up to 8x improved colorectal cancer detection and up to 8x lung cancer screening efficiency